Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities by Davies, Lynne, Milner, Jr, Danny A, Shulman, Lawrence N, Kyokunda, Lynnette, Bedada, Alemayehu, Vuylsteke, Peter, Masalu, Nestory, Jackson, Paul, Jennings, Natanya, Odunlami, Adesumbo, Mtshali, Phangisile, Dugan, Ute

Get full text

765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of t... by O’Reilly, Eileen M, O’Hara, Mark H, Fisher, George, Wolff, Robert A, Wainberg, Zev A, Ko, Andrew H, Arnott, Jamie, Cabanski, Christopher R, Upadhaya, Samik, Saez-Ibanez, Ana Rosa, Campbell, Jay, Francis, James, Rosen, Oliver, Bucktrout, Samantha, Boffo, Silvia, Dugan, Ute, O’Donnell-Tormey, Jill, Vonderheide, Robert H, Khalil, Danny

Get full text

Multisector Collaborations and Global Oncology: The Only Way Forward by Blanchard, Charmaine, Lubuzo, Buhle, Asirwa, Frederick Chite, Dlamini, Xolisile, Msadabwe-Chikuni, Susan C, Mwachiro, Michael, Shyirambere, Cyprien, Ruhangaza, Deo, Milner, Jr, Dan A, Van Loon, Katherine, DeBoer, Rebecca, Mtshali, Phangisile, Dugan, Ute, Baker, Ellen, Shulman, Lawrence N

Get full text

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, mult... by O'Hara, Mark H, O'Reilly, Eileen M, Varadhachary, Gauri, Wolff, Robert A, Wainberg, Zev A, Ko, Andrew H, Fisher, George, Rahma, Osama, Lyman, Jaclyn P, Cabanski, Christopher R, Mick, Rosemarie, Gherardini, Pier Federico, Kitch, Lacey J, Xu, Jingying, Samuel, Theresa, Karakunnel, Joyson, Fairchild, Justin, Bucktrout, Samantha, LaVallee, Theresa M, Selinsky, Cheryl, Till, Jacob E, Carpenter, Erica L, Alanio, Cécile, Byrne, Katelyn T, Chen, Richard O, Trifan, Ovid C, Dugan, Ute, Horak, Christine, Hubbard-Lucey, Vanessa M, Wherry, E John, Ibrahim, Ramy, Vonderheide, Robert H

Get full text

Novel Regimens of Capecitabine Alone and Combined with Irinotecan and Bevacizumab in Colorectal Cancer Xenografts by KOLINSKY, Kenneth, ZHANG, Yu-E, DUGAN, Ute, HEIMBROOK, David, PACKMAN, Kathryn, HIGGINS, Brian

Get full text

Antitumor Activity of Capecitabine and Bevacizumab Combination in a Human Estrogen Receptor-negative Breast Adenocarcinoma Xenograft Model by HIGGINS, Brian, KOLINSKY, Kenneth, LINN, Michael, ADAMES, Violeta, ZHANG, Yu-E, MOISA, Carlos, DUGAN, Ute, HEIMBROOK, David, PACKMAN, Kathryn

Get full text

Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated... by O'Hara, Mark H., O'Reilly, Eileen M., Rosemarie, Mick, Varadhachary, Gauri, Wainberg, Zev A., Ko, Andrew, Fisher, George A., Rahma, Osama, Lyman, Jaclyn P., Cabanski, Christopher R., Carpenter, Erica L., Hollmann, Travis, Gherardini, Pier Federico, Kitch, Lacey, Selinsky, Cheryl, LaVallee, Theresa, Trifan, Ovid C., Dugan, Ute, Hubbard-Lucey, Vanessa M., Vonderheide, Robert H.

Get full text

In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models by Kolinsky, Kenneth, Shen, Ben-Quan, Zhang, Yu-E, Kohles, Joseph, Dugan, Ute, Zioncheck, Thomas F, Heimbrook, David, Packman, Kathryn, Higgins, Brian

Get full text

In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir by MIN JIANG, MANI, Nagraj, MÜH, Ute, HANZELKA, Brian, TIGGES, Ann, RIJNBRAND, Rene, KIEFFER, Tara L, CHAO LIN, ARDZINSKI, Andrzej, NELSON, Michelle, REAGAN, Dugan, BARTELS, Doug, YI ZHOU, NICOLAS, Olivier, GOVINDA RAO, B

Get full text